Management tracks

Protein degradation newco C4 Therapeutics Inc. (Cambridge, Mass.) hired Andrew Phillips as CSO. He was senior director of the center for development of therapeutics at the Broad Institute of MIT and Harvard.

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), which is developing complement factor D ( CFD; adipsin) inhibitors for ultra-rare diseases, named Martha Manning EVP and general counsel, and Amy Jennings SVP of regulatory affairs. Manning was general counsel at iCeutica Inc (Philadelphia, Pa.). Jennings was head of U.S. regulatory for diabetes at Sanofi (Euronext:SAN; NYSE:SNY). ...